# Beijing Scitech-Mq Pharmaceuticals

Source: https://onco.cc/companies/beijing-scitech-mq-pharmaceuticals/  
OnCo record `beijing-scitech-mq-pharmaceuticals` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Beijing Scitech-Mq Pharmaceuticals is a Chinese developer in Beijing that sponsors 3 registered cancer trials of ST-1898.

## Summary

Beijing Scitech-Mq Pharmaceuticals appears on ClinicalTrials.gov as the industry sponsor of 3 interventional cancer trials (phase 1/2, 2), testing ST-1898 in unresectable or metastatic melanoma, advanced renal cell carcinoma, differentiated thyroid carcinoma. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Beijing Scitech-Mq Pharmaceuticals Limited
- Tags: ctgov-sponsor; china; registry-only
- HQ: Beijing, China
- Type: biotech

## Sources

- ClinicalTrials.gov: trials sponsored by Beijing Scitech-Mq Pharmaceuticals: https://clinicaltrials.gov/search?spons=Beijing%20Scitech-Mq%20Pharmaceuticals

## Connected records

- trials: [A Study of ST-1898 for Unresectable or Metastatic Melanoma](https://onco.cc/trials/nct06359860/), [Study of ST-1898 in Advanced Renal Cell Carcinoma](https://onco.cc/trials/nct06127238/), [Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer](https://onco.cc/trials/nct06359847/)

---
JSON: https://onco.cc/api/v1/entities/beijing-scitech-mq-pharmaceuticals.json